This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

47/100

✓ Peer-reviewed alzhub usefulness score 47 out of 100. Health systems and care delivery

Topic: Amyloid, tau and blood-test diagnosis

Among non-dually eligible beneficiaries, 9.0% (95% confidence interval [CI]: 8.0, 9.1) with ADRD disenrolled while 19.7% (95% CI: 19.6, 19.9) switched plans within MA compared to a disenrollment rate of 4.2% (95% CI: 4.2, 4.2) and switching rate of 22.8% (95% CI: 22.9, 22.8) for persons without ADRD. MA enrollees with ADRD tend to disenroll at substantially higher rates than those without ADRD. This may be indicative of their care needs not being met in the program.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Meyers, D. J., Rahman, M., Rivera‐Hernandez, M., Trivedi, A. N., & Mor, V. (2021). Plan switching among Medicare Advantage beneficiaries with Alzheimer's disease and other dementias. Alzheimer s & Dementia Translational Research & Clinical Interventions. https://doi.org/10.1002/trc2.12150

Vancouver

Meyers DJ, Rahman M, Rivera‐Hernandez M, Trivedi AN, Mor V. Plan switching among Medicare Advantage beneficiaries with Alzheimer's disease and other dementias. Alzheimer s & Dementia Translational Research & Clinical Interventions. 2021. doi:10.1002/trc2.12150. PMID: 33778149.

BibTeX

@article{meyers2021-33778149,
  author  = {Meyers, David J. and Rahman, Momotazur and Rivera‐Hernandez, Maricruz and Trivedi, Amal N. and Mor, Vincent},
  title   = {{Plan switching among Medicare Advantage beneficiaries with Alzheimer's disease and other dementias}},
  journal = {Alzheimer s \& Dementia Translational Research \& Clinical Interventions},
  year    = {2021},
  doi     = {10.1002/trc2.12150},
  pmid    = {33778149},
  url     = {https://doi.org/10.1002/trc2.12150}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Among non-dually eligible beneficiaries, 9.0% (95% confidence interval [CI]: 8.0, 9.1) with ADRD disenrolled while 19.7% (95% CI: 19.6, 19.9) switched plans within MA compared to a disenrollment rate of 4.2% (95% CI: 4.2, 4.2) and switching rate of 22.8% (95% CI: 22.9, 22.8) for persons without ADRD.
MA enrollees with ADRD tend to disenroll at substantially higher rates than those without ADRD.
This may be indicative of their care needs not being met in the program.

Why it matters

Among non-dually eligible Medicare Advantage beneficiaries, those with Alzheimer disease and related dementias disenrolled at higher rates (9.0%) than those without (4.2%). This may indicate that their care needs are not being met in the program.

Study details

Effect size9.0%; 19.7%; 4.2%
Evidence strengthLow

How this study scored 47/100

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomised / blinded because the record does not state it.

Component	Points	Why
Journal tier	7 / 10	Tier 3 — peer-reviewed journal (Alzheimer s & Dementia Translational Research & Clinical Interventions)
Journal's citation record	1 / 4	Alzheimer s & Dementia Translational Research & Clinical Interventions: journal h-index 84 (OpenAlex, 2026-10-29)
Study design	0 / 12	No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence	1 / 5	Rated “low” in our summary
Peer-review validation	10 / 10	Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent	3 / 5	2021 — within 6 year(s) of the newest study here
Sample size	0 / 4	Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported	2 / 3	Effect reported as a number, without an interval or test
Studied in people	0 / 3	Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded	0 / 2	No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited	3 / 7	Cited 39 times (OpenAlex, 2026-10-10)
Citations per year	2 / 5	5.6 citations a year over 7 year(s) since 2021
Impact for its field and year	3 / 6	Cited 4.5× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here	3 / 6	Cited by 19 other studies in this library
Still being cited	2 / 4	Cited 23 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record	4 / 4	Last-listed author Vincent Mor: h-index 108 (OpenAlex, whole career)
Institution's track record	1 / 3	Brown University: institution h-index 1,120 (OpenAlex)
Multi-centre collaboration	1 / 3	OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed	2 / 2	Indexed in PubMed (PMID 33778149)
Free to read	2 / 2	Free to read
Total	47 / 100	—

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

18 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.

Related studies in Health systems and care delivery

Also in Health systems and care delivery

172 studies in the library are filed under Health systems and care delivery with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Health systems and care delivery hub.

Similar studies

More on Health systems and care delivery

See all studies in Health systems and care delivery →